A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2006
11/21/2006	US7138133 Orally administered liquid compositions
11/21/2006	CA2338753C Medicinal aerosol formulations
11/21/2006	CA2334718C Quinoline derivatives
11/21/2006	CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
11/21/2006	CA2140441C Inhibitors of c-amp phosphodiesterase and tnf
11/16/2006	WO2006122200A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1)
11/16/2006	WO2006122154A2 Pyridone derivatives for modulating stress-activated protein kinase system
11/16/2006	WO2006122137A1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity
11/16/2006	WO2006121207A1 Methods for damaging cells using effector function of anti-dsc2 antibody
11/16/2006	WO2006120580A2 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
11/16/2006	WO2006002840A3 Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant
11/16/2006	WO2005053648A8 Pre-metered dry powder inhaler for moisture-sensitive medicaments
11/16/2006	US20060258848 Human antipneumococcal antibodies from non-human animals
11/16/2006	US20060258839 Cardiovascular disorders; antiinflammatory agents; resemble a G amphipathic helix of apolipoprotein J; phospholipids
11/16/2006	US20060258742 Hydroxy tetrahydro-naphthalenylurea derivatives
11/16/2006	US20060258702 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258660 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258612 CFTR channel modulators
11/16/2006	US20060258585 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/16/2006	US20060257989 Truncated aggrecanase molecules
11/16/2006	US20060257965 Extracellular matrix signalling molecules
11/16/2006	US20060257928 ANGE gene in atopy
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	US20060257414 Mycoplasma gallisepticum formulation
11/16/2006	US20060257364 Materials and methods for inhibition of IgE production
11/16/2006	US20060257351 administering, to a subject a formulation containing2-(3,4-dihydroxyphenyl)ethanol or a glucoside; and cysteine or cystine for potentiating glutathione, for promoting the production of a gamma -glutamylcysteine synthetase, glutathione reductase; antiaging agents, nutraceuticals, sunscreen agents
11/16/2006	US20060257330 Powdery pharmaceutical compositions for inhalation
11/16/2006	CA2608116A1 Method of modulating stress-activated protein kinase system
11/16/2006	CA2607929A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1)
11/16/2006	CA2607806A1 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
11/16/2006	CA2607331A1 Combination of the pde4 inhibitor roflumilast and a tetrahydrobiopterin derivative
11/15/2006	EP1721905A1 Thiazole derivative
11/15/2006	EP1721610A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
11/15/2006	EP1721608A2 Upregulation of type III endothelial cell nitric oxide synthase by HMG-CoA reductase inhibitors
11/15/2006	EP1720854A1 Phthalzinone derivatives as pde4 inhibitors
11/15/2006	EP1720847A1 Histamine-3 receptor modulators
11/15/2006	EP1720835A1 Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors
11/15/2006	EP1720577A2 Ciclesonide and glycopyrronium combination
11/15/2006	EP1720554A1 Use of meloxicam for the treatment of respiratory diseases in pigs
11/15/2006	EP1720552A2 Methods for treating inflammatory and autoimmune diseases
11/15/2006	EP1720546A1 Novel, sustained-action beta-2-agonists and their use as medicaments
11/15/2006	EP1720543A1 Roflumilast and glycopryrronium combination
11/15/2006	EP1511482B1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
11/15/2006	EP1423121B1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
11/15/2006	EP1414443B1 BENZIMIDAZO 4,5-f\|ISOQUINOLINONE DERIVATIVES
11/15/2006	EP1411881B9 5ht2c receptor modulators
11/15/2006	EP1410040B1 Method for identifying substances which modulate interleukin 4 (il-4) signaling
11/15/2006	EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/15/2006	EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	EP1283731B1 Medicament dispensing system with a medicament container with same side airflow inlet and outlet
11/15/2006	EP0969836B1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006	CN1863784A 2-naphthylimino-1,3-thiazine derivative
11/15/2006	CN1861177A Medicinal composition for treating children cold and its prepn. process
11/15/2006	CN1861165A Honey-prepared chuanbei Huangpi medicinal syrup contg. tendril-leaved fritillary bulb
11/15/2006	CN1861153A Medicinal composition used for treating pharyngitis, its prepn. method and its quality control method
11/15/2006	CN1861131A Qingkailing dixinwan pill prepn. and its prepn. method
11/15/2006	CN1861107A Thin coating medicine for treating cold and its prepn. method
11/15/2006	CN1861106A Compound isatis root effervescent tablet and its prepn. method
11/15/2006	CN1861102A Tablets for promoting prodn. of body-fluid and nourishing throat
11/15/2006	CN1861098A Calmophil, pharmaceutical composition and producing method
11/15/2006	CN1861084A Compound fluorophenylnico injection, prepn. method and use thereof
11/15/2006	CN1861073A Use of malic polyphenols for preparing medicine to treat pharyngolaryngitis
11/15/2006	CN1861072A Use of malic polyphenols for preparing medicines to treat bronchitis or asthma
11/15/2006	CN1860897A Product for clearing-heat and moistening-throat, and its prepn. method
11/15/2006	CN1284585C Medicine for treating acute and chronic pharyogolaryngitis, recurring oral cavity sore and its preparation method
11/15/2006	CN1284573C Oral administration or lozenge medicine for treating acute pharyngitis and acute tonsillitis
11/15/2006	CN1284555C Compound fineleaf schizonepeta oil soft capsule
11/15/2006	CN1284547C Use of pilose asiabell and astragalus composition in preventing and treatnig acute pulmonary hurt
11/15/2006	CN1284546C Thesium Chinese total flavone preparation method
11/15/2006	CN1284528C Orally administered dripping pills prepared by hive body
11/15/2006	CN1284526C Method for preparing powdered injection of 'Shuanghuanglian' formulation
11/14/2006	US7135607 Shows symptoms of diffuse alveolar hemorrhage, glomerulonephritis, and appearance of antikidney glomerular basement membrane antibody; immunizing with type IV collagen homozygous transgenic mouse whose genome comprises a disruption of the FC gamma RIIB gene; diagnosis, drug screening
11/14/2006	US7135600 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis
11/14/2006	US7135572 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
11/14/2006	US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
11/14/2006	US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines
11/14/2006	US7135497 Spinal administration of at least one beta 2 adrenergic agonist such as clenbuterol and salbutamol; neurodegenerative diseases; improved locomotor function and neuromuscular strength
11/14/2006	US7135494 Antitumoral carbazoles
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135453 Reagents and methods for smooth muscle therapies
11/14/2006	US7135452 Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation
11/14/2006	US7135279 4-alpha glucotransferases; enzymes inhibitors; enantimorphs; adrenergic blocking agents; proteases; superoxide dismutases; carbonic anhydrases
11/14/2006	US7135195 Colorless antimicrobioal aqueous suspension of colloidal silver particles having an interior of elemental silver and a surface of silver oxide of given particle diameters; antiseptic and surface disinfectant and for treatment of viral, fungal, and bacterial infections
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/14/2006	CA2340320C Use of an angiogenic factor for the treatment of microascular angiopathies
11/14/2006	CA2263846C Novel pyranoside derivatives
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/09/2006	WO2006118328A1 Degranulation inhibitor
11/09/2006	WO2006118320A1 Thienopyrimidone compound
11/09/2006	WO2006118299A1 Gpcr inhibitor

1 ... 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 ... 878